The serotonin 5-HT 2A and glutamate mGlu 2 receptors continue to attract particular attention, given their implication in psychosis associated with schizophrenia and the mechanism of action of atypical antipsychotics and a new class of antipsychotics, respectively. A large body of evidence indicates a functional crosstalk between both receptors in the brain, but the underlying mechanisms are not entirely elucidated. Here, we have explored the influence of 5-HT 2A receptor upon the phosphorylation pattern of mGlu 2 receptor in light of the importance of specific phosphorylation events in regulating G protein-coupled receptor signaling and physiological outcomes. Among the five mGlu 2 receptor-phosphorylated residues identified in HEK-293 cells, the phosphorylation of Ser 843 was enhanced upon mGlu 2 receptor stimulation by the orthosteric agonist LY379268 only in cells co-expressing the 5-HT 2A receptor. Likewise, administration of LY379268 increased mGlu 2 receptor phosphorylation at Ser 843 in prefrontal cortex of wild-type mice but not 5-HT 2A −/− mice. Exposure of HEK-293 cells co-expressing mGlu 2 and 5-HT 2A receptors to 5-HT also increased Ser 843 phosphorylation state to a magnitude similar to that measured in LY379268-treated cells. In both HEK-293 cells and prefrontal cortex, Ser 843 phosphorylation elicited by 5-HT 2A receptor stimulation was prevented by the mGlu 2 receptor antagonist LY341495, while the LY379268-induced effect was abolished by the 5-HT 2A receptor antagonist M100907. Mutation of Ser 843 into alanine strongly reduced G i/o signaling elicited by mGlu 2 or 5-HT 2A receptor stimulation in cells co-expressing both receptors. Collectively, these findings identify mGlu 2 receptor phosphorylation at Ser 843 as a key molecular event that underlies the functional crosstalk between both receptors.
Introduction
Among the 14 5-hydroxytryptamine (serotonin, 5-HT) receptor subtypes, the 5-HT 2A receptor still raises special interest, given its role in the psychotropic effects of psychedelic hallucinogens, which are often used to probe the psychosis associated with schizophrenia, and in the therapeutic effects of atypical antipsychotics like clozapine, olanzapine, and risperidone, which act as antagonists or inverse agonists of the receptor [1, 2] . Atypical antipsychotics are efficient against positive symptoms of schizophrenia (hallucinations, delusions, and disorder of thought), but they poorly control negative symptoms (social isolation, anhedonia, and inactivity) and are often not efficient against cognitive symptoms (poor "executive functioning", lack of attention, and impaired working memory) [3] . During the 90s, a new class of antipsychotics acting as orthosteric agonists (LY354740, LY379268, and LY404039) or positive allosteric modulators (PAMs, LY487379, and BINA) of group II metabotropic glutamate receptors (mGlu 2 / 3 ) has been developed. Subsequent preclinical studies indicated that mGlu 2 receptor activation accounts for their antipsychotic activity [4] [5] [6] and showed overall superiority over 5-HT 2A receptor antagonists in alleviating negative symptoms. Furthermore, an integrated study combining five placebo-controlled trials of pomaglumetad, the oral prodrug of LY404039, demonstrated clinical efficacy of glutamate-based pharmacotherapy in schizophrenia in specific patient subgroups, such as patients at early disease stage and, interestingly, patients who had never been treated with 5-HT 2A receptor antagonists [7] . 5-HT 2A and mGlu 2 receptors are canonically coupled to G q and G i/o proteins, respectively, and thus induce different signaling cascades, but they do not function as independent targets of antipsychotics. Electrophysiological and behavioral studies have demonstrated a functional antagonism between 5-HT 2A and mGlu 2 receptors: pharmacological activation of mGlu 2 receptor inhibits glutamate release and excitatory postsynaptic currents (EPSCs) elicited by 5-HT 2A receptor stimulation in the prefrontal cortex, and attenuates behavioral effects of hallucinogens, while mGlu 2 receptor antagonists further enhance the frequency and amplitude of 5-HT 2A receptor-induced EPSCs [7, 8] . It has recently been proposed that the functional crosstalk between both receptors does not solely occur at the level of neuronal networks or intracellular signaling cascades, but that it involves the formation of 5-HT 2A -mGlu 2 heteromers, which integrate inputs from ligands of each protomer to trigger unique signaling and behavioral outcomes [9] . In vitro and in vivo data identified the 5-HT 2A -mGlu 2 heterocomplex as a possible target of hallucinogenic 5-HT 2A receptor agonists that mediates engagement of G i/o signaling and the associated psychotropic effects [9] . Conversely, 5-HT 2A -mGlu 2 heteromers are necessary for the stimulation of G q signaling by mGlu 2 receptor agonists, which is altered in patients with schizophrenia [10] . This particular signaling also depends on the ability of mGlu 2 receptor to couple to and activate G i/ o proteins [10] . Finally, studies showed that 5-HT 2A -mGlu 2 heteromers serve as an integration point that determines the balance between G i/o and G q -dependent signaling, and pro-psychotic (increase in G q vs. G i/o signaling) vs. antipsychotic (increase in G i/o vs. G q signaling) outcome [11] . These findings pinpoint the role of 5-HT 2A -mGlu 2 heteromers in the homeostatic equilibrium between G i/o and in G q signaling that ensures a normal non-psychotic state. However, the existence of 5-HT 2A -mGlu 2 heteromers and their physiological relevance still remain controversial in absence of unequivocal demonstration of the colocalization of both receptors in neurons [12] . There is even predominant evidence for a presynaptic localization of mGlu 2 receptors, while 5-HT 2A receptors are mainly localized at the post-synapse [12] .
Given the importance of specific phosphorylation events in determining the signaling and physiological outcomes of G protein-coupled receptors (GPCRs) [13] , phosphorylation of 5-HT 2A and mGlu 2 receptors is another mechanism that might contribute to the functional crosstalk between both receptors, irrespective of heteromer formation. In a previous study, we extensively characterized 5-HT 2A receptorphosphorylated sites and identified a serine residue in the third receptor intracellular loop (Ser 280 ) phosphorylated in response to receptor activation by hallucinogenic 5-HT 2A receptor agonists, such as lysergic acid diethylamide (LSD) or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), but not by non-hallucinogenic agonists, such as lisuride or ergotamine [14] . This study also showed that the phosphorylation of Ser 280 underlies the lower propensity of hallucinogens to induce receptor desensitization and internalization, compared with non-hallucinogenic agonists [14] . These data suggest that biased phosphorylation of 5-HT 2A receptor by hallucinogenic vs. non-hallucinogenic agonists might account for their distinct behavioral outcomes upon long-term treatment. Using an in vitro phosphorylation assay, another study also identified several residues phosphorylated in the mGlu 2 receptor C-terminal domain and showed that the phosphorylation of one of them (Ser 843 ) by protein kinase A (PKA) affects receptor coupling to G proteins [15] . However, the reciprocal influence of 5-HT 2A and mGlu 2 receptors on their phosphorylation state and the role of their phosphorylation in the functional crosstalk between both receptors remain unexplored.
Here, we characterized phosphorylated residues of mGlu 2 receptor expressed in HEK-293 cells and investigated the influence of 5-HT 2A receptor expression/stimulation upon their phosphorylation state using high-resolution mass spectrometry. Among the identified residues, we show that Ser 843 phosphorylation elicited by agonist stimulation of mGlu 2 receptor depends on 5-HT 2A receptor coexpression and demonstrate a reciprocal interplay between the activation of both receptors to promote Ser 843 phosphorylation. Characterization of the signaling outcome of Ser 843 phosphorylation revealed its key role in G i/o signaling elicited by 5-HT 2A and mGlu 2 receptors agonists in cells co-expressing both receptors.
Materials and methods

Materials
Human Embryonic Kidney-293 (HEK-293) N type cells (RRID:CVCL_0045) were from the American Type Culture Collection (Anassas, VI, ATCC, CRL-1573). All experiments of the study were performed using a previously characterized batch of cells (Isolate #3) [16] . Their negative mycoplasma status was analyzed every month using the MycoAlert Mycoplasma Detection Kit (Lonza, Switzerland). Culture media were from Invitrogen. M100907 maleate was a generous gift from Dr Jean-Michel Rivet (Institut de Recherches Servier, Croissy-sur-Seine, France). LY379268 (mGlu 2 receptor orthosteric agonist), LY341495 (mGlu 2 receptor antagonist), KT5720 (PKA inhibitor), and D4476 (casein kinase 1 inhibitor) were from Tocris, lisuride maleate from Santa Cruz Biotechnologies, 5-HT, and DOI from Sigma-Aldrich. Pertussis toxin (PTX) was from Calbiochem ® and FR900359 was produced as previously described [17] .
The rat anti-hemagglutinin (HA) antibody (11867423001) was from Roche, the rabbit anti-Flag antibody (F7425) and the mouse anti-Flag M2 antibody conjugated to magnetic beads (M8823) were from Sigma-Aldrich. The rabbit anti-CK1ε (#12448) was from Cell Signaling and the mouse anti-Actin (#MA5-11869) was from Thermo Scientific. The anti-phospho-Ser 843 antibody was generated by immunizing rabbits with the synthetic CAAPRAsANLGQG peptide coupled to KLH (Eurogentec ® ). Antibodies were purified by two consecutive affinity chromatographies. A first chromatography against the immobilized phosphorylated CAA-PRAsANLGQG peptide as bait bound antibodies recognizing both phosphorylated and unphosphorylated forms of the peptide. The retained fraction was then eluted and used for a second chromatography against the immobilized non-phosphorylated CAAPRASANLGQG peptide. We considered that the non-retained fraction of the second chromatography step contains antibodies recognizing mGlu 2 receptor phosphorylated at Ser 843 .
The PRK5 plasmid encoding the HA-tagged 5-HT 2A receptor was described elsewhere [18] . The cDNA encoding HA-tagged 5-HT 2A (D 120 N) was generated by site-directed mutagenesis from this plasmid. The pcDNA3 plasmids encoding the Flag-tagged human and rat mGlu 2 receptors were generously provided by Dr. Philippe Rondard (Institut de Génomique Fonctionnelle, Montpellier, France). The cDNAs encoding human and rat S 843 A mGlu 2 receptors and human S 843 D and S 844 A mGlu 2 receptor were obtained by gene synthesis (Eurogentec ® ) and subcloned in pcDNA3. The pcDNA3 plasmid encoding human CaV2.2 calcium channel isoform and the single dual promotor plasmid (pDuo) encoding rat Cavα 2 -δ 1-b and Cavβ 1b ancillary subunits cloned in a single dual promotor plasmid (pDuo) were described elsewhere [19] . The peGFPC1 plasmid was from Clontech.
Cell cultures and transfection
HEK-293 cells were grown in Dulbecco's modified Eagle's medium + GlutaMAX (Life Technologies) supplemented with 10% dialyzed, heat-inactivated fetal calf serum (BioWhittaker) and antibiotics in a humidified 5% CO 2 incubator at 37°C. They were transfected at 40-50% confluence using polyethyleneimine (Sigma-Aldrich), as previously described [20] , and used 48 h after transfection. CKIε short interfering RNA (siRNA; FlexiTube siRNA CKIε;
Cat.N°SI00287735/SI00287728/SI04434843/ SI04434836) and control siRNA (AllStars Negative Control siRNA; Cat.N°107280) were purchased from QIAGEN. siRNA transfection in HEK-293 cells (at 40-50% confluence) was performed with Lipofectamine ® 2000 (Invitrogen) according to the manufacturer's protocol using a final siRNA concentration of 10 nM. Cells were used 48 h after transfection.
Quantitative mass spectrometry analysis of mGlu 2 receptor phosphorylation
Transfected cells were starved of serum for 4 h, challenged with either vehicle or LY379268 (1 μM) for 15 min, and lysed in Triton X-100 (2%), sodium chloride (150 mM), Tris-HCl (50 mM, pH 7.5), EDTA (2 mM), EGTA (2 mM), SDS (0.2%), sodium orthovanadate (1 mM), sodium fluoride (50 mM), sodium β-glycerophosphate (25 mM), sodium pyrophosphate (5 mM), and a protease inhibitor cocktail (Roche). The samples were incubated under rotation for 1 h at 4°C and centrifuged for 15 min at 16,000×g to eliminate insoluble material. Flag-tagged mGlu 2 receptor was immunoprecipitated from 10 mg protein extracts using the anti-Flag M2 antibody immobilized on magnetic beads. After reduction with dithiothreitol (10 mM, 10 min at 37°C) and alkylation with iodoacetamide (50 mM, 45 min at 25°C), immunoprecipitated mGlu 2 receptors were resolved by SDS-PAGE and digested in-gel with trypsin (10 ng/mL, Gold, Promega) or with chymotrypsin (10 ng/mL, Gold, Promega) overnight at 25°C. Peptides were analyzed by nano-flow liquid chromatography coupled to Fourier transform tandem mass spectrometry (nano-LC-FT-MS/ MS) using a LTQ Velos Pro Orbitrap Elite mass spectrometer coupled to an Ultimate 3000 (Thermo Fisher Scientific). Desalting and pre-concentration of samples were performed online on a Pepmap precolumn (0.3 mm 10 mm, Dionex) in buffer A (2% acetonitrile, 0.1% formic acid). A gradient consisting of 2-40% buffer B (B = 99.9% acetonitrile with 0.1% formic acid; 3-33 min), 40-80% B (33-34 min), 80-0% B (49-50 min), and equilibrated for 20 min in 0% B (50-70 min) was used to elute peptides at 300 nL/min from a Pepmap capillary reversed-phase column (0.075 × 150 mm, Thermo Fisher Scientific). Mass spectra were acquired using a top-10 collision-induced dissociation data-dependent acquisition method. The LTQ-Orbitrap was programmed to perform a FT full scan (60,000 resolution) on 400-1400 Th mass range with the top-10 ions from each scan selected for LTQ-MS/MS with multistage activation on the neutral loss of 24.49, 32.66, and 48.99 Th. FT spectra were internally calibrated using a single lock mass (445.1200 Th). Target ion numbers were 500,000 for FT full scan on the Orbitrap and 10,000 MSn on the LTQ. Precursor mass and top 6 per 30 Da windows peak lists were extracted from MS2 using MSconvert 3.0 and searched with Mascot 2.6 against the human or rat Complete Proteome Set database (http://www.uniprot.org), cysteine carbamidomethylation as a fixed modification and phosphorylation of Ser, Thr, and Tyr as variable modifications, 7 ppm precursor mass tolerance, 0.5 Da fragment mass tolerance, and trypsin/P or chymotrypsin digestion. MS2 spectra matching phosphorylated peptides with ion score over 15 were manually inspected for unique transitions that pinpoint the position of phosphorylation sites. Ion signals corresponding to phosphorylated peptides were quantified from the maximal intensities measured in their ion chromatograms manually extracted using Qual browser v2.1 (Thermo Fisher Scientific) with a tolerance of 5 ppm for mass deviation, and normalized to signals of their non-phosphorylated counterparts. For each identified phosphorylated residue, a phosphorylation index (phosphorylated peptide ion signal intensity/(phosphorylated peptide ion signal intensity + non-phosphorylated peptide ion signal intensity)) was calculated.
Western blotting
Proteins, resolved onto 10% polyacrylamide gels, were transferred electrophoretically to nitrocellulose membranes (Bio-Rad). Membranes were immunoblotted with primary antibodies (anti-phospho-Ser 843 mGlu 2 receptor, 1:2000; anti-Flag, 1:1000; Anti-HA, 1:1000) and then with either anti-rat (Jackson ImmunoResearch 112-035-003) or anti-rabbit (Sigma-Aldrich GENA934V) or anti-mouse (Sigma-Aldrich GENA931V) horseradish peroxidase (HRP)-conjugated secondary antibodies (1:5000). Immunoreactivity was detected with an enhanced chemiluminescence method (Western lightning® Plus-ECL, Perkin Elmer) on a ChemiDoc Tm Touch Imaging System (Bio-Rad). Immunoreactive bands were quantified by densitometry using the ImageJ software (v.1.50). In protein phosphorylation analyses, the amount of each phosphoprotein was normalized to the amount of the corresponding total protein detected in the sample.
Analysis of Ser 843 phosphorylation in the mouse prefrontal cortex
Experiments on mice (C57/Bl6J, 8 weeks old, male) conformed to European ethics standards (86/609-EEC) and to decrees of the French National Ethics Committee (N°87/ 848) for the care and use of laboratory animals. Protocols were approved by regional ethic committee for animal use (CEEA LR 34, #7251). A minimum of four animals was used for each group. Animals were randomly allocated into the different groups by an observer who was blind to the experimental conditions. Prior to immunochemistry, brains were randomly numbered in order to perform immunochemistry and image acquisition in a blind way and reassign the samples to their group afterwards. Mice (~20 g) were injected intraperitoneally (i.p.) with either vehicle (5% DMSO/5% Tween-80) or LY379268 (10 mg/kg) or DOI (10 mg/kg) or lisuride (10 mg/kg). M100907 (5 mg/kg) or LY341495 (3 mg/kg) were injected 15 min prior to vehicle or agonists. LY379268 was also administered to 5-HT 2A −/− [21] and mGlu 2 −/− [22] mice (originally provided by Professor Shigetada Nakanishi at Kyoto University, Japan), and DOI to mGlu 2 −/− mice. Thirty min after agonist injection, mice were anesthetized with pentobarbital (100 mg/kg i.p., Ceva SA) and perfused transcardiacally with fixative solution containing 4% w/v paraformaldehyde, 0.1 M sodium phosphate buffer (pH 7.5), sodium fluoride (10 mM), and sodium orthovanadate (2 mM). Brains were post-fixed for 48 h in the same solution and stored at 4°C. Thirty µm-thick sections were cut with a vibratome (Leica). Sections were incubated with a solution containing 0.2% Triton X-100, 3% bovine serum albumin (BSA) and 2% goat serum in Tris buffer saline (TBS) for 30 min. They were then incubated for 24 h at 4°C with the anti-phospho-Ser 843 antibody (1:500) in TBS containing 3% BSA. After four washes, they were incubated for 1 h with an Alexa Fluor® 488conjugated anti-rabbit antibody (1:2000, Invitrogen) in TBS containing 2.5% BSA and 0.08% Triton X-100. Immunofluorescent staining was observed with a Zeiss Axioimager Z1 microscope equipped with apotome (Carl Zeiss). Images were acquired using the Zen2 (blue edition) software driving an AxioCam MRm CCD camera (Carl Zeiss). Image analysis was performed with the ImageJ software (v1.50), and results were expressed in percentage of anti-phospho-Ser 843 -positive cells relative to DAPIstained cells.
ELISA
Quantification of cell surface expression of HA-tagged 5-HT 2A receptors and Flag-tagged wild-type, S 843 A and S 843 D mGlu 2 receptors was performed by ELISA under non-permeabilized conditions, as previously described [23] . Dilutions for primary antibodies were 1:400 (Anti-HA) and 1:1000 (anti-Flag). Secondary antibodies (donkey antimouse or anti-rabbit conjugated to HRP, GE Healthcare) were used at 1:5000 dilution. Immunoreactive signal was detected with a M200 Infinite plate reader (Tecan), using the SuperSignal ELISA Femto chromogenic substrate (Thermo Scientific). Control experiments were performed using cells transfected with empty vectors.
Electrophysiology HEK-293 cells were co-transfected with plasmids encoding Flag-tagged wild-type or S 843 A or S 843 D mGlu 2 receptor, HA-tagged 5-HT 2A receptor, Cav2.2, Cavβ 1b and Cavα 2 -δ 1-b ancillary subunits, and GFP (to detection of transfected cells). Twenty-four hours after transfection, cells were dissociated with Versene (Invitrogen) and plated at low density in poly-ornithine-coated 35-mm Petri dishes for 24 h. Cells were incubated with extracellular solution containing 125 mM NaCl, 20 mM TEACl, 10 mM HEPES, 5 mM BaCl 2 , and 1 mM MgCl 2 and pH was adjusted to 7.3 with TEAOH. Borosilicate glass pipettes (2-4 MΩ, Sutter Instrument) were filled with internal solution containing 130 mM CsCl, 10 mM HEPES, 10 mM EGTA, 2 mM CaCl 2 , 1 mM MgCl 2 , 4 mM MgATP, and 0.3 mM Tris-GTP (pH adjusted to 7.3 with NaOH). Currents were elicited from a holding potential of −80-0 mV during 10 ms repeated each 1 s. Data were plotted as means ± SEM. Statistical difference (p < 0.05) was determined using one-way analysis of variance.
Statistics
Statistical analyses were performed using Prism (v. 7.0, GraphPad Software Inc.). Histograms show means ± SEMs. One-way ANOVA followed by Tukey's and Dunnett's tests were performed for multiple comparisons to multiple groups or to a single group, respectively. For each statistical test, F value was calculated in order to determine how the variance between the mean values obtained in different populations is significantly different. F value, number of independent biological replicates, and sample size (or number of animals per condition) are indicated in the corresponding figure legends. MS peptide identification probabilities were calculated using the Mascot algorithm. Mascot score represents −10×LOG10(p value), where p value is the absolute probability of peptide wrong assignment.
Results
Agonist-stimulated mGlu 2 receptor phosphorylation at Ser 843 requires co-expression of 5-HT 2A receptor in HEK-293 cells
To identify novel molecular substrates of the functional crosstalk between 5-HT 2A and mGlu 2 receptors, we first examined the phosphorylation pattern of Flag-tagged human mGlu 2 receptor co-expressed with HA-tagged 5-HT 2A receptor in HEK-293 cells following exposure to vehicle or a maximally effective concentration of the mGlu 2 receptor orthosteric agonist LY379268 (1 µM) [24] . mGlu 2 receptors were purified by immunoprecipitation followed by SDS-PAGE. They were then digested in-gel with trypsin. Analysis of peptides from vehicle or LY379268-treated cells by nano-flow liquid chromatography coupled to highresolution tandem mass spectrometry (nano-LC-MS/MS) yielded 57% coverage of the entire receptor sequence and 75% coverage of intracellular domains, with a p value threshold of 0.05 for peptide identification ( Supplementary  Figure 1 ). LC-MS/MS analysis identified one phosphorylated residue located in the third extracellular domain of the receptor (Thr 718 ) and four residues in the C-terminal domain (Ser 833 , Ser 837 , Ser 843/844 , and Ser 871 , Table 1 , Fig. 1a , Supplementary Figures 2-5 ). Note that MS/MS fragmentation did not discriminate between a phosphorylation at Ser 843 or Ser 844 , due to the absence of site-specific fragment ions in MS/MS spectra ( Supplementary Figure 4) . In an effort to distinguish Ser 843 from Ser 844 phosphorylation, purified mGlu 2 receptor was digested with chymotrypsin to generate a proteolytic peptide with the two serine residues located in the central part of the sequence, which should be enriched in discriminant fragment ions. Unfortunately, chymotrypsin digestion yielded only 31% receptor sequence coverage (Supplementary Figure 6A ) and the two theoretically discriminant ions were not detected in the corresponding fragmentation spectra (Supplementary Figure 6B ). Alignment of human, mouse, and rat mGlu 2 receptor sequences revealed that the region encompassing Ser 843 and Ser 844 is highly conserved in the three species (Fig. 1b) . Specifically, Ser 843 of the human receptor is conserved in rat and mouse orthologs, whereas Ser 844 is replaced by an alanine (Fig. 1b ). We thus renewed the experiments in cells expressing the rat mGlu 2 receptor and clearly identified a peptide phosphorylated at Ser 843 ( Supplementary Figure 7) . Consistent with these findings, a peptide comprising phosphorylated Ser 843 was likewise identified in cells expressing the S 844 A mutant of the human mGlu 2 receptor (Supplementary Figure 8 ), while no peptide phosphorylated at Ser 844 was detected in cells expressing the S 843 A mutant. Collectively, these results unambiguously identify Ser 843 as the phosphorylated residue in the human and murine receptors.
To explore the impact of agonist stimulation of mGlu 2 receptor and 5-HT 2A receptor expression upon mGlu 2 receptor phosphorylation, we next compared the phosphorylation index of each identified phosphorylated residue in cells exposed or not to LY379268, in the presence or absence of 5-HT 2A receptor. The phosphorylation index of Thr 718 , Ser 833 , Ser 837 , and Ser 871 did not display any significant variation upon exposure of cells to LY379268 or co-expression of 5-HT 2A receptor (Table 1 and Supplementary Figures 2B, 3B, 5B ). In contrast, LY379268 induced a marked increase in Ser 843 phosphorylation in cells co-expressing human mGlu 2 and 5-HT 2A receptors, while it did not significantly affect its phosphorylation state in cells expressing mGlu 2 receptor alone ( Fig. 1c ). Likewise, LY379268 exposure of cells expressing the rat mGlu 2 receptor increased Ser 843 phosphorylation only when the 5-HT 2A receptor was co-expressed ( Fig. 1c and Supplementary Figure 7 ). Collectively, these findings demonstrate that agonist stimulation of mGlu 2 receptor induces the phosphorylation of a conserved serine residue in human and murine receptors in HEK-293 cells, an effect dependent of the presence of 5-HT 2A receptor.
Agonist-stimulated mGlu 2 receptor phosphorylation at Ser 843 in the mouse prefrontal cortex requires coexpression of 5-HT 2A receptor A polyclonal antibody against the mGlu 2 receptor phosphorylated at Ser 843 was obtained by immunizing a rabbit with the synthetic CAAPRAsANLGQG peptide encompassing a phosphorylated serine residue corresponding to Ser 843 in the entire murine receptor. We checked the specificity of the antibody for the phosphorylated site by immunoblotting on HEK-293 cell protein extracts. No immunoreactive signal was observed in blots from cells transfected with empty vector, but a clear signal was detected at the expected molecular weight in blots obtained from cells expressing the rat mGlu 2 receptor (Supplementary Figure 9 ). Furthermore, LY379268 treatment strongly enhanced this immunoreactive signal only in cells coexpressing the 5-HT 2A receptor, consistent with the results of MS analysis ( Fig. 1c and Supplementary Figure 9 ). Mutation of Ser 843 into alanine abolished this immunoreactive signal, confirming the specificity of the antibody for phosphorylated Ser 843 ( Supplementary Figure 9 ). The maximal signal intensity was reached at LY379268 concentration as low as 1 nM (Supplementary Figure 10A) .
Notably, expression of 5-HT 2A receptor at various densities (in absence of LY379268) did not enhance phosphorylation of Ser 843 of mGlu 2 receptor (Supplementary Figure 11) . As expected, the increase in Ser 843 phosphorylation induced by LY379268 was prevented by the co-application of the mGlu 2 receptor antagonist LY341495 (10 µM, Supplementary Figure 12 ). An increase in the anti-phospho-Ser 843 antibody immunoreactivity was also observed in western blots from cells expressing the human mGlu 2 receptor, although the intensity of the immunoreactive signal was much lower than that measured in cells expressing the rat receptor ( Supplementary Figure 13 ), suggesting a higher affinity of our anti-phospho-Ser 843 antibody for the murine phosphorylated receptor. We next took advantage of this antibody to investigate the phosphorylation of native mGlu 2 receptor in the mouse prefrontal cortex, a brain region where mGlu 2 /5-HT 2A heteromers have been identified [9] . We injected mice with either vehicle of LY379268 (10 mg/kg, 30 min) and assessed mGlu 2 phosphorylation by immunohistochemisty. Reminiscent of the data obtained in HEK-293 cells, LY379268 administration strongly increased immunostaining with the anti-phospho-Ser 843 antibody (Fig. 1d ). The most intense signal was observed in middle layers of prefrontal cortex, which express the highest density of 5-HT 2A receptor [25] . As observed in HEK-293 cells, Ser 843 phosphorylation elicited in mouse prefrontal cortex by injecting LY379268 was also prevented by the administration of LY341495, which alone did not affect Ser 843 phosphorylation ( Fig. 1d ). Confirming the specificity of our antibody for phosphorylated mGlu 2 , no signal was detected in prefrontal cortex of mGlu 2 receptor knockout (mGlu 2 −/− ) mice treated with either vehicle or LY379268 (Fig. 1d ). Moreover, administration of LY379268 to 5-HT 2A receptor knockout (5-HT 2A −/− ) mice did not increase the phospho-Ser 843 immunoreactive signal in prefrontal cortex (Fig. 1d) , indicating that 5-HT 2A receptor expression is also necessary for LY379268-induced phosphorylation of native mGlu 2 receptor at Ser 843 . In order to identify protein kinase(s) involved in Ser 843 phosphorylation, mGlu 2 receptor sequence surrounding Ser 843 was uploaded into Group-based Prediction System (GPS © , v3.0), a software for kinase consensus search that ranks protein kinases into a hierarchical tree with four levels and builds its algorithm against the PhosphoELM database, in order to calculate false discovery rates for each of them [26] . GPS search revealed that Ser 843 is a good consensus for phosphorylation by casein kinase 1 (CK1, GPS © score 9.3), and cyclic AMP-dependent protein kinase (PKA, GPS © score 4.1), consistent with previous findings [15] . Pretreatment of HEK-293 cells co-expressing mGlu 2 and 5-HT 2A receptor with the CK1 inhibitor D4476 (10 µM, 60 min) [27] abolished LY379268-induced phosphorylation of Ser 843 , whereas the PKA pharmacological inhibitor KT5720 (1 µM, 60 min) [28] did not affect the level of Ser 843 phosphorylation ( Fig. 2a ), suggesting that CK1 rather than PKA promotes Ser 843 phosphorylation in living cells. Treatment of cells with D4476 did not affect the low Ser 843 phosphorylation level measured in cells expressing mGlu 2 receptor alone and challenged with LY379268 ( Supplementary Figure 14) .
Among the CK1 isoforms, GPS search pointed CK1δ and CK1ε as the best candidates that are able to phosphorylate Ser 843 . Given the high CK1ε expression level and the very low expression of CK1δ in prefrontal cortex (http://mouse.brain-map.org/), we targeted specifically the ε isoform using RNA interference. Silencing CK1ε expression abolished LY379268-induced Ser 843 phosphorylation in cells co-expressing 5-HT 2A receptor (Fig. 2b and Supplementary Figure 15 ), reminiscent of the effect of cell exposure to D4476 (Fig. 2a ).
G i/o and G q proteins are involved in Ser 843 phosphorylation elicited by mGlu 2 receptor stimulation in cells co-expressing 5-HT 2A receptor
In line with the canonical coupling of mGlu 2 and 5-HT 2A receptors to G i/o and G q proteins, respectively, we next explored their influence on LY379268-induced Ser 843 phosphorylation in cells co-expressing both receptors. LY379268 exposure did not increase Ser 843 phosphorylation in cells pretreated with the G i/o inhibitor PTX (100 ng/ mL, 18 h) or the pharmacological G q/11 inhibitor FR900359 (1 μM, 2 h) [17] , indicating that the activation of both G i/o and G q/11 is necessary for LY379268-induced Ser 843 phosphorylation (Supplementary Figure 16A) . Further supporting the role of G q/11 activation by unliganded 5-HT 2A receptor, LY379268 exposure did not promote Ser 843 phosphorylation in cells expressing the signaling-dead 5-HT 2A (D 120 N) receptor (Supplementary Figure 17A) [29] . 2 receptor, with or without HA-tagged 5-HT 2A receptor, were exposed to either Vehicle or LY379268 (1 µM, 15 min). To determine the role of Ser 843 phosphorylation in mGlu 2 receptor-mediated signal transduction, we measured mGlu 2 receptor-operated inhibition of N-type voltage-gated calcium channels, a readout commonly used to study engagement of G i/o signaling by GPCRs [30, 31] (Fig. 3a) . As expected, LY379268 inhibited N-type calcium channel-mediated current in a concentration-dependent manner (pEC 50 = 8.81 ± 0.16, n = 10 cells) in HEK-293 cells transiently expressing mGlu 2 receptor (Fig. 3b ). No effect of LY379268 was seen in cells transfected with an empty vector or transiently expressing the 5-HT 2A receptor alone, but co-expression of 5-HT 2A receptor with mGlu 2 receptor increased the amplitude of LY379268-induced inhibition of N-type calcium channels without affecting its apparent affinity (pEC 50 = 8.66 ± 0.07, n = 10 cells, Fig. 3b ). In contrast, co-expression of 5-HT 2A receptor with S 843 A mGlu 2 receptor mutant did not enhance the LY379268-induced inhibition of N-type calcium channels, while mutation of Ser 843 into aspartate, to mimic permanent phosphorylation of this residue, had no consequence on the level of inhibition of the N-type calcium channels by LY379268 (Fig. 3c ). Furthermore, pretreatment of cells with the CK1 inhibitor D4476 (10 µM), which prevented Ser 843 phosphorylation, also abolished the potentiation of the LY379268 response elicited by 5-HT 2A receptor expression in cells co-expressing wild-type mGlu 2 receptor but not in cells co-expressing S 843 D mGlu 2 receptors ( Fig. 3c ). D4476 exposure did not affect the amplitude of LY379268-induced inhibition of N-type calcium channels in cells expressing mGlu 2 receptor alone (Fig. 3c ). Collectively, these results suggest that Ser 843 phosphorylation is a necessary step of the potentiation of mGlu 2 receptoroperated G i/o signaling induced by 5-HT 2A receptor expression. This potentiation was not due to an enhanced expression of mGlu 2 receptor at the plasma membrane, as ELISA experiments showed that co-expression of 5-HT 2A receptors did not change the cell surface expression of mGlu 2 receptor ( Supplementary Figure 18) . Further supporting the absence of influence of Ser 843 phosphorylation on mGlu 2 receptor plasma membrane localization, wildtype, S 843 A and S 843 D mGlu 2 receptors exhibited similar cell surface expression ( Supplementary Figure 18 ).
5-HT 2A receptor stimulation promotes phosphorylation of mGlu 2 receptor at Ser 843
Exposure of HEK-293 cells co-expressing mGlu 2 and 5-HT 2A receptors to 5-HT increased Ser 843 phosphorylation state in a concentration-dependent manner and to a magnitude similar to that measured in LY379268-treated cells ( Figs. 1c and 4a, Supplementary Figure 10B) , an effect prevented by the 5-HT 2A receptor antagonist M100907 (100 nM, Fig. 4a ). Reminiscent of the LY379268-induced response, the 5-HT-induced Ser 843 phosphorylation was strongly reduced in cells expressing the G q -dead 5-HT 2A (D 120 N) receptor (Supplementary Figure 17B) . Likewise, the 5-HT-elicited Ser 843 phosphorylation was abolished in cells pretreated with FR900359, but it persisted in cells pretreated with PTX ( Supplementary Figure 16B) . The hallucinogenic 5-HT 2A receptor agonist DOI (10 µM) and the non-hallucinogenic agonist lisuride (10 µM)-induced increases in Ser 843 phosphorylation comparable to that measured in cells challenged with 5-HT (Fig. 4b) . Furthermore, no additional increase in Ser 843 phosphorylation state was measured in cells exposed to both LY379268 and 5-HT 2A receptor agonists (5-HT, DOI, or lisuride, Fig. 4b ).
Corroborating results obtained in transfected HEK-293 cells, administration of DOI (10 mg/kg, 30 min), or lisuride (10 mg/kg, 30 min) to mice induced elevations of Ser 843 phosphorylation in the prefrontal cortex similar to those measured in mice injected with LY379268 ( Fig. 4c ). As expected, Ser 843 phosphorylation elicited by DOI injection was prevented by the administration of M100907, which alone did not affect Ser 843 phosphorylation (Fig. 4c ). Collectively, these results indicate that Ser 843 phosphorylation can be triggered with similar efficiencies by agonist stimulation of either 5-HT 2A or mGlu 2 receptors in cells coexpressing both receptor subtypes.
Interestingly, treatment of HEK-293 cells co-expressing 5-HT 2A and mGlu 2 receptors with LY341495, which alone did not affect Ser 843 phosphorylation, inhibited the 5-HTinduced effect (Fig. 5a ). Conversely, M100907 prevented the LY379268-induced increase in Ser 843 phosphorylation, while it slightly but not significantly decreased basal Ser 843 phosphorylation (Fig. 5b) . mGlu 2 and 5-HT 2A receptor ligands induced similar regulations of Ser 843 phosphorylation in mouse prefrontal cortex: Ser 843 phosphorylation elicited by injecting LY379268 was prevented by the administration of M100907 and, reciprocally, the DOIinduced effect was prevented by the administration of LY341495 (Fig. 5c ). Collectively, these observations indicate that phosphorylation of Ser 843 elicited by the stimulation of 5-HT 2A receptor depends on the co-expression of mGlu 2 receptor at active conformation and vice versa.
Impact of 5-HT 2A receptor activation on G i/odependent signaling under the control of mGlu 2 receptor
Given the role of Ser 843 phosphorylation in mGlu 2 receptoroperated activation of G i/o signaling and the critical influence of the 5-HT 2A receptor upon this phosphorylation, we also investigated the effect of 5-HT 2A receptor stimulation on G i/o signaling by measuring the activity of N-type calcium channels. In cells expressing 5-HT 2A receptor alone, 5-HT (1 µM) already induced a weak inhibition of N-type calcium channels (Fig. 5d ). This inhibition was more pronounced in cells co-expressing wild-type or S 843 D mGlu 2 receptors, but not in cells co-expressing S 843 A mGlu 2 Flag-tagged wild-type mGlu 2 receptor alone or in combination with HA-tagged 5-HT 2A receptor, were exposed to increasing concentrations of LY379268. Each point represents the means ± SEM of percentage of N-type calcium channel current inhibition measured in 10 cells from three different sets of cultured cells. c Left panel: cells, expressing Flag-tagged mGlu 2 receptor alone or co-expressing HAtagged 5-HT 2A receptor and either wild-type or S 843 A or S 843 D Flagtagged mGlu 2 receptor, were exposed to 1 µM LY379268. Right panel: HEK-293 cells, expressing Flag-tagged mGlu 2 receptor alone or coexpressing HA-tagged 5-HT 2A receptor and either wild-type or S 843 D mGlu 2 receptor, were treated with vehicle or D4476 (10 µM, delivered via the patch pipette 5 min before the LY379268 challenge). Representative traces of N-type calcium channel currents in conditions not depicted in b are illustrated. Histograms represent the means ± SEM of N-type calcium channel current inhibition induced by LY379268 in 10 cells from three independent cultures. One-way ANOVA (post hoc: Tukey's range test): F(3,36) = 16.94, p < 0.0001; F(5,54) = 17.15, p < 0.0001 in left and right panels, respectively. ***p < 0.001 receptor (Fig. 5d ). Reminiscent of their influence upon Ser 843 phosphorylation, both LY341495 and M100907 prevented LY379268-and 5-HT-induced inhibition of N-type calcium channels (Fig. 5e ). Collectively, these data suggest a reciprocal interplay between 5-HT 2A and mGlu 2 receptors in engagement of G i/o signaling, which depends on Ser 843 phosphorylation.
Discussion
Phosphorylation of GPCRs is classically considered as a mechanism initiating receptor desensitization and βarrestin-dependent receptor internalization following sustained agonist exposure [32] . More recently, subtle modifications of GPCR phosphorylation at specific sites have emerged as key molecular substrates that determine the nature of GPCR-operated signaling, depending on the ligand (functional selectivity) or the cell type, that can be tailored to meet a specific physiological function [33] [34] [35] [36] [37] [38] . It has also been suggested that GPCR heteromerization can influence the phosphorylation status of the different heteromer constituents, which in turn modulates signaling and physiological outcome of the heteromer. For instance, a recent study has shown that the RF-amide peptide NPFF, by acting at NPFF 2 receptors, induces a transphosphorylation of Mu-opioid receptor within Mu/NPFF 2 heteromers, a process responsible for a loss of function of Mu receptors and contributing to the tolerance to morphine analgesia induced by NPFF [39] . These observations highlight the functional and physiological impact of GPCR phosphorylation within heterocomplexes and underscore the potential of deciphering the phosphorylation events on each subunit of GPCR heteromers to elucidate the mechanism of action of psychotropic drugs. They provided the impetus for the present phosphoproteomics screen aimed at characterizing the influence of 5-HT 2A receptor expression and stimulation upon mGlu 2 receptor phosphorylation pattern.
We and two previously not described phosphorylated sites (Ser 718 and Ser 837 ) in human mGlu 2 receptor co-expressed with 5-HT 2A receptor in HEK-293 cells challenged with a mGlu 2 receptor agonist. The absence of manual inspection of MS/MS spectra pinpointing the phosphorylated sites referenced in the PhosphoSi-tePlus database suggests that the majority of the previously described sites are actually not fully validated, although one cannot rule out that the difference between our results and the previously reported ones might reflect the distinct biological samples and experimental conditions used.
Among the five sites identified in the present study, only the phosphorylation of a serine residue (Ser 843 ) located in the receptor C-terminal domain and conserved in the human and rat sequences was upregulated upon agonist receptor stimulation. Moreover, Ser 843 phosphorylation depended on the co-expression of 5-HT 2A receptor. Likewise, phosphorylation of mGlu 2 receptor at Ser 843 elicited in mice prefrontal cortex by peripheral administration of the mGlu 2 receptor agonist LY379268 (assessed by immunohistochemistry using a newly generated phospho-Ser 843 antibody) was not seen in 5-HT 2A −/− mice. This result indicates that the joint influence of 5-HT 2A and mGlu 2 receptors upon Ser 843 phosphorylation can be observed on both recombinant receptors and native receptors expressed in prefrontal cortex, a brain structure co-expressing both receptors and important for the behavioral responses to 5-HT 2A and mGlu 2 receptor ligands [9, 40] . Intriguingly, 5-HT 2A receptor stimulation by 5-HT promoted Ser 843 phosphorylation as efficiently as that induced by mGlu 2 receptor stimulation, reminiscent of the transphosphorylation of Muopioid receptor elicited by NPFF receptor activation [39] . Moreover, Ser 843 phosphorylation induced by 5-HT (or the synthetic 5-HT 2A receptor agonist DOI) was impaired by the mGlu 2 receptor antagonist LY341495, while the LY379268-induced effect was prevented by the 5-HT 2A receptor antagonist M100907, thus demonstrating a positive reciprocal influence of both receptor activities upon mGlu 2 receptor phosphorylation at Ser 843 in HEK-293 cells and mouse prefrontal cortex. Notably, the LY379268-induced Ser 843 phosphorylation depends on both G i/o and G q activation, whereas the 5-HT-induced response is only G qdependent. Collectively, these findings suggest that Ser 843 HT-stimulated 5-HT 2A receptor that is independent of mGlu 2 receptor stimulation by its own agonist and of G i/o protein activation. However, one cannot rule out that 5-HT 2A receptor-dependent Ser 843 phosphorylation can also be induced indirectly via a 5-HT 2A receptor-operated G q/11 signaling pathway. Irrespective of the mechanism underlying Ser 843 phosphorylation, our results identify a novel functional crosstalk mechanism between 5-HT 2A and mGlu 2 receptors at the receptor level. The demonstration of this crosstalk in mouse prefrontal cortex strongly supports the colocalization of at least a fraction of both receptors expressed in this brain area and, possibly, the formation of 5-HT 2A -mGlu 2 heteromers in vivo.
The difference in signal transduction elicited by hallucinogenic and non-hallucinogenic agonists of the 5-HT 2A receptor represents one of the best characterized examples of functional selectivity translated into distinct behaviors [21, 41] . Furthermore, we previously showed that the two categories of 5-HT 2A receptor agonists differ in their capacities to promote 5-HT 2A receptor phosphorylation at Ser 280 [14] . Such a biased phosphorylation was not retrieved for Ser 843 : treatment of cells with the hallucinogenic agonist DOI and the non-hallucinogenic agonist lisuride induced comparable increases in Ser 843 phosphorylation to that elicited by 5-HT. It is thus unlikely that Ser 843 phosphorylation underlies the distinct behavioral responses induced by both ligand categories.
Among the two kinases possibly involved in Ser 843 phosphorylation suggested by the GPS algorithm, namely CK1 and PKA, our data based on pharmacological inhibitors and CK1 expression silencing suggest that this phosphorylation is mediated by CK1. This contrasts with previous findings, which demonstrated that Ser 843 can be phosphorylated in vitro by PKA or following a treatment of cells expressing recombinant mGlu 2 receptor with the adenylyl cyclase activator forskolin or cell-permeable cAMP analogs. Hence, CK1 rather than PKA seems to be involved in the more physiological context of agonist mGlu 2 receptor stimulation in cells co-expressing 5-HT 2A receptors, consistent with the canonical coupling of mGlu 2 receptors to G i/ o proteins and their ability to inhibit rather than stimulate cAMP production [42] . CK1 activity generally depends on its expression level or the expression of regulators, which are likely not affected by acute extracellular stimuli [43, 44] . In light of the well-established formation of 5-HT 2A -mGlu 2 heteromers, at least in recombinant cells [9, 34] , we hypothesize that Ser 843 might be accessible for CK1 only in a mGlu 2 receptor conformation stabilized by its association with 5-HT 2A receptor and agonist stimulation of either mGlu 2 or 5-HT 2A receptor within the heterocomplex [45] .
Consistent with the localization of Ser 843 in mGlu 2 receptor C-terminal domain, a region important for coupling to G proteins, several lines of evidence suggest that its phosphorylation is an essential step in engagement of G i/o signaling not only upon mGlu 2 receptor activation but also following 5-HT 2A receptor activation in cells co-expressing both receptors: (i) corroborating previous findings indicating that heteromeric assembly of mGlu 2 and 5-HT 2A receptors enhances glutamate-elicited G i/o signaling [11] , co-expression of 5-HT 2A receptor with mGlu 2 receptor enhanced LY379268-induced inhibition of N-type channels (used as readout of activation of G i/o -dependent signaling) Fig. 5 Reciprocal influence of mGlu 2 and 5-HT 2A receptor stimulation upon G i/o signaling depends on Ser 843 phosphorylation. a HEK-293 cells co-expressing Flag-tagged mGlu 2 receptor and HA-tagged 5-HT 2A receptor were exposed to vehicle or 5-HT (1 µM), alone or in combination with LY341495 (10 µM), or to LY341495 alone (10 µM) for 15 min. b HEK-293 cells co-expressing Flag-tagged mGlu 2 receptor and HA-tagged 5-HT 2A receptor were exposed for 15 min to vehicle or LY379268 (10 nM), in the absence or presence of M100907 (100 nM). In (a,b), mGlu 2 receptor phosphorylation was analyzed by sequential immunoblotting with the anti-phospho-Ser 843 antibody and the anti-Flag antibody. Representative blots of three independent experiments performed on different sets of cultured cells are illustrated. The histograms show the means ± SEM of the anti-phospho-Ser 843 mGlu 2 receptor immunoreactive signal relative to Flag immunoreactive signal (expressed in arbitrary units, a.u.) obtained in the three experiments. One-way ANOVA (post hoc: Tukey's range test): F (3,8) = 22.49, p = 0.0003 and F(3,8) = 28.97, p = 0.0001 in (a,b), respectively. **p < 0.01, ***p < 0.001. c Mice were injected with either DOI (10 mg/kg, i.p.), LY379268 (10 mg/kg, i.p.). M100907 (5 mg/kg, i.p.) and LY341495 (3 mg/kg, i.p.) were injected 15 min before vehicle/LY379268/DOI administration. Representative images showing phospho-Ser 843 -mGlu 2 immunofluorescent staining in prefrontal cortex are illustrated. The histogram shows the mean ± SEM of values (expressed in % of anti-phospho-Ser 843 -positive cells relative to DAPIstained cells) obtained in four animals per group. One-way ANOVA (post hoc: Tukey's range test): F(5,18) = 24.57, p < 0.0001. ***p < 0.001. Scale bar: 100 µm. d HEK-293 cells, transiently expressing 5-HT 2A receptor alone or in combination with either wild-type or S 843 A or S 843 D mGlu 2 receptor, were exposed to 1 µM 5-HT. Representative traces of N-type calcium channel currents obtained after exposure to vehicle or 5-HT are shown. The histograms represent the means ± SEM of N-type calcium channel current inhibition measured for each treatment in 10 cells originating from three independent cultures. Oneway ANOVA (post hoc: Tukey's range test): F(3,36) = 13.45, p < 0.0001. ***p < 0.001. e Left panels: HEK-293 cells co-expressing 5-HT 2A and mGlu 2 receptors were sequentially challenged with LY3792968 (10 nM), LY341495 (10 µM), and LY3792968 + LY341495 or with 5-HT (1 µM), M100907 (100 nM), and 5-HT + M100907. Right panels: cells were sequentially challenged with LY3792968, M100907, and LY3792968 + M100907 or with 5-HT, LY341495, and 5-HT + LY341495. Representative traces of N-type calcium channel currents obtained after 5-HT or LY3792968 challenges (in absence or presence of M100907 or LY341495) are illustrated. The histograms represent the means ± SEM of N-type calcium channel current inhibition measured for each condition in 10 cells originating from three independent cultures. Note that M100907 or LY341495 alone did not alter the N-type calcium channel current. One-way ANOVA (post hoc: Tukey's range test): F(3,36) = 89.9, p < 0.0001; F(3,36) = 78.18, p < 0.0001 in left and right panels, respectively. ***p < 0.001 [30, 31] , an effect suppressed by mutating Ser 843 into alanine; (ii) reminiscent of their influence upon Ser 843 phosphorylation, the 5-HT 2A receptor antagonist M100907 prevented enhancement of LY379268-induced inhibition of N-type channels induced by the co-expression of 5-HT 2A receptor, while the mGlu 2 receptor antagonist LY341495 blocked the 5-HT-evoked response. These findings thus identify Ser 843 phosphorylation as a novel molecular substrate underlying the functional crosstalk between 5-HT 2A and mGlu 2 receptors, which determines the level of G i/o signaling under the control of both receptors. It has been proposed that the balance between G i/o and G q -dependent signaling determines pro-psychotic vs. antipsychotic activity of 5-HT 2A and mGlu 2 receptor ligands [11] . Given the critical influence of Ser 843 phosphorylation level on mGlu 2 and 5-HT 2A receptor-dependent G i/o signaling, its finetuning might be an essential mechanism contributing to the homeostatic balance that ensures a normal non-psychotic state.
In conclusion, the present study identifies Ser 843 phosphorylation as an early molecular substrate of the functional crosstalk between 5-HT 2A and mGlu 2 receptors that determines the level of G i/o signaling under the control of both receptors, which itself might be predictive of antipsychotic or pro-psychotic effects of drugs targeting each receptor. Accordingly, the anti-phospho-Ser 843 antibody developed in this study might be a relevant tool for the screening of potential antipsychotic drugs in preclinical models of schizophrenia. Several studies also reported changes in 5-HT 2A and mGlu 2 receptor densities in patients with schizophrenia, which might contribute to the pathogenicity of the disease [9, 12, 46] . Although the data show some discrepancies and must be considered cautiously because of the potential impact of antipsychotic drug treatment on 5-HT 2A receptor expression, the majority of post-mortem studies demonstrate a decrease in cortical 5-HT 2A receptor density in patients. In line with these findings and the strong influence of 5-HT 2A receptor expression/stimulation on Ser 843 phosphorylation, analysis of its phosphorylation status in postmortem brain of patients with schizophrenia might be of great interest.
